'A Moral Hazard': Kalshi Drug Trial Bets Spark Ethical Qualms
Kalshi Inc. opening prediction markets for clinical drug trials has raised a host of compliance concerns for attorneys, including the risk of insider trading among the wide swaths of stakeholders in...To view the full article, register now.
Already a subscriber? Click here to view full article